Clinical Interchange™: Breaking Down the Barriers in Cystic Fibrosis — Evolving Your Management Strategies to Match the Needs of an Older Population

Release Date: October 30, 2020
Expiration Date: October 30, 2021

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in the management of cystic fibrosis (CF) in adult patients. In this educational program, these experts discuss diagnostic testing in adult patients suspected to have CF, the clinical features that differ between adult and pediatric patients, and special considerations in adult patients with CF, including endocrine disorders, infertility, and issues that arise as patients age. They also review treatment, including the impact of CFTR modulators, and the important role of the multidisciplinary team in supporting the adult patient with CF.

Acknowledgement of Support

This activity is supported by an educational grant from Vertex Pharmaceuticals Incorporated.

Target Audience

This activity is intended for CF specialists, pulmonologists, gastroenterologists, nurse practitioners/physician assistants, respiratory therapists, and other health care professionals who manage patients with cystic fibrosis.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

• Describe the patient journey for the adult with cystic fibrosis (CF)
• Discuss the pathophysiology of atypical CF as it relates to the adult patient
• Identify the addressable factors that contribute to improved care for adults with CF
• Analyze the efficacy and safety of current and emerging therapies in the management of adult patients with CF
• Develop multidisciplinary team-based management strategies to improve quality of life in adult patients with CF

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Chair

Raksha Jain, MD, MSc
Medical Director of the Adult Cystic Fibrosis Program
Dedman Family Scholar in Clinical Care
Associate Professor
Department of Internal Medicine
UT Southwestern Medical Center
Dallas, TX

Disclosures: Raksha Jain, MD, MSc, has no relevant financial relationships with commercial interests.

Faculty

Nauman Chaudary, MD, FCCP, FACP
Professor of Medicine
Director, Adult Cystic Fibrosis
Division of Pulmonary Medicine and Critical Care Diseases
Virginia Commonwealth University Health System
Richmond, VA

Disclosures: Advisory Board: Genentech, Gilead and Chiesi. Study PI: Gilead, Genentech, Vertex Pharmaceuticals. Grant/Research: Cystic Fibrosis Foundation (CFF), Cystic Fibrosis Foundation Therapeutics, Acomm Inc, Vertex Pharmaceuticals

Amir Moheet, MBBS
Associate Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism
Endocrinologist
University of Minnesota
Minneapolis, MN

Disclosures: Grant/Research: National Institutes of Health, IDRF, CFF.

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.